# Trevi Therapeutics Inc

Type: Company (TRVI)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/trevi-therapeutics-inc
Canonical HTML page: https://getbiobrief.com/entity/trevi-therapeutics-inc

## Recent coverage (1 stories)

### Biotech Q4 Earnings: Trevi Beats Expectations as Cibus Navigates Fiscal Hurdles
2026-03-18 04:10:02 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Trevi Therapeutics and Cibus Inc reported Q4 2025 results, highlighting a divergence in fiscal health as Trevi outperformed earnings expectations while Cibus faced mounting financial pressure. Both companies remain focused on high-stakes technical milestones, with Trevi advancing its lead asset Haduvio and Cibus pushing gene-edited crop traits toward commercialization.
Full story: https://getbiobrief.com/story/trevi-cibus-q4-2025-earnings-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.